Predicta Biosciences: Funding, Investors & Team (Sep 2026)
Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.
Predicta Biosciences has raised $23.4M across 1 funding round on record, the most recent a Series A of $23.4M announced in Sep 2025.
That round is above the $12M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Predicta Biosciences Company Profile and Key Stats
Latest funding round on record: Sep 2025.
Predicta Biosciences Funding Rounds
Predicta Biosciences Founders and Leadership Team
Contact details for the Predicta Biosciences team: 1 of 2 have an email address on file.
Start 14-day free trial →Predicta Biosciences Funding Compared to Other Biotechnology Startups
Predicta Biosciences' latest round of $23.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Predicta Biosciences in Biotechnology and Boston
Companies Similar to Predicta Biosciences
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and…
Rion Vet mission is to drive the regenerative medicine revolution.
Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.
Nomax Therapeutics develops a healthcare technology platform to provide therapies for neurodegenerative…
Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate…
Gut Brain Axis Therapeutics is a biotechnology company that offers treatment for Autism Spectrum Disorder…
iOrganBio is a pioneering cell production platform.
BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.
NILO Therapeutics is a biotechnology and therapeutics company.
AccufyDx is a Biotechnology Research firm working to change MRD analysis for early detection.Accufy…
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.
Reprogenix is a groundbreaking medical technology firm
Predicta Biosciences Funding FAQs
What does Predicta Biosciences do?
Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for hematological diseases.
How much funding has Predicta Biosciences raised?
Predicta Biosciences has raised $23.4M across 1 round on record. The most recent is a Series A of $23.4M announced in Sep 2025.
When did Predicta Biosciences last raise funding?
Predicta Biosciences' most recent funding round on record is a Series A of $23.4M, announced in Sep 2025.
Who founded Predicta Biosciences?
FundedIQ lists Gad Getz (Founder) at Predicta Biosciences.
Who is the CEO of Predicta Biosciences?
Brian McKernan is listed as CEO at Predicta Biosciences.
Where is Predicta Biosciences headquartered?
Predicta Biosciences is based in Boston, United States.
How many employees does Predicta Biosciences have?
Predicta Biosciences is in the 11-50 employee band.
How does Predicta Biosciences' funding compare to other Biotechnology startups?
Predicta Biosciences' latest round of $23.4M is above the $12M median round size for Biotechnology companies on FundedIQ across 27 tracked companies over the last two years.
About FundedIQ's Predicta Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Predicta Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.